tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market
Holding CRNX?
Track your performance easily

Crinetics Pharmaceuticals (CRNX) Financial Statements

479 Followers

Crinetics Pharmaceuticals Financial Overview

Crinetics Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.717; its P/E ratio is -15.34; Crinetics Pharmaceuticals is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.90. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-$ 399.00K$ 640.00K-$ 346.00K
Gross Profit-$ 399.00K$ 640.00K-$ 346.00K
EBIT$ -76.83M$ -74.06M$ -73.53M$ -62.66M$ -58.98M
EBITDA$ -76.06M$ -69.45M$ -73.06M$ -62.40M$ -58.70M
Net Income Common Stockholders$ -76.83M$ -74.04M$ -66.93M$ -60.10M$ -57.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 862.67M$ 862.95M$ 900.96M$ 558.55M$ 554.65M
Total Assets$ 937.37M$ 935.53M$ 978.15M$ 635.35M$ 641.54M
Total Debt$ 52.54M$ 53.32M$ 52.50M$ 51.73M$ 52.17M
Net Debt$ -810.13M$ -809.63M$ -848.46M$ -506.83M$ -502.48M
Total Liabilities$ 104.39M$ 104.77M$ 103.22M$ 96.25M$ 93.79M
Stockholders Equity$ 832.98M$ 830.75M$ 874.97M$ 539.11M$ 547.75M
Cash Flow-
Free Cash Flow$ -63.35M$ -46.57M$ -54.19M$ -39.45M$ -44.84M
Operating Cash Flow$ -62.82M$ -45.62M$ -52.86M$ -38.52M$ -41.34M
Investing Cash Flow$ 20.60M$ -53.64M$ 309.00K$ -87.31M$ -193.30M
Financing Cash Flow$ 57.33M$ 5.50M$ 393.57M$ 37.92M$ 337.88M
Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History

Crinetics Pharmaceuticals Debt to Assets

Crinetics Pharmaceuticals Cash Flow

Crinetics Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis